LEPETTA 083 415 6431 10046T:@0.057132:0.975660:0.057132:0.919812:0.048975:0.919812:0.048975:0.975660:0.000000:0.000000:0.000000:0.011620:0.003102:0.002447:0.008089:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.047876
*Women of childbearing potential should be using consistent and reliable contraception:@0.070706:0.893865:0.345285:0.893865:0.345285:0.884653:0.070706:0.884653:0.003797:0.006658:0.003899:0.006312:0.003695:0.004123:0.001598:0.003899:0.002321:0.001598:0.003074:0.004123:0.001873:0.001944:0.004062:0.004062:0.003695:0.003706:0.002525:0.001873:0.004123:0.004062:0.001598:0.004062:0.003899:0.002596:0.003695:0.004123:0.002596:0.001873:0.003706:0.001944:0.001598:0.002942:0.004123:0.003899:0.004052:0.001944:0.004062:0.001598:0.004062:0.003695:0.001598:0.004052:0.002942:0.001873:0.004123:0.004062:0.001598:0.003074:0.003899:0.004123:0.002942:0.001873:0.002942:0.002596:0.003695:0.004123:0.002596:0.001598:0.003706:0.004123:0.004062:0.001598:0.002525:0.003695:0.001944:0.001873:0.003706:0.004062:0.001944:0.003695:0.001598:0.003074:0.003899:0.004123:0.002596:0.002525:0.003706:0.003074:0.003695:0.004062:0.002596:0.001873:0.003899:0.004123
2:@0.345278:0.890466:0.347563:0.890466:0.347563:0.885095:0.345278:0.885095:0.002285
Caution is advised when prescribing Nuvaco to women of child bearing age as there is an associated risk of neural tube defects to children exposed to (DTG/Nuvaco) during pregnancy. :@0.070706:0.901639:0.638188:0.901639:0.638188:0.892427:0.070706:0.892427:0.003797:0.003706:0.004052:0.002596:0.001873:0.003899:0.004123:0.001598:0.001873:0.002942:0.001598:0.003706:0.004062:0.003532:0.001873:0.002942:0.003695:0.004062:0.001598:0.005762:0.004123:0.003695:0.004123:0.001598:0.004062:0.002525:0.003695:0.002942:0.003074:0.002525:0.001873:0.004062:0.001873:0.004123:0.004062:0.001598:0.004734:0.004052:0.003532:0.003706:0.003074:0.003899:0.001598:0.002596:0.003899:0.001598:0.005762:0.003899:0.006312:0.003695:0.004123:0.001598:0.003899:0.002321:0.001598:0.003074:0.004123:0.001873:0.001944:0.004062:0.001598:0.004062:0.003695:0.003706:0.002525:0.001873:0.004123:0.004062:0.001598:0.003706:0.004062:0.003695:0.001598:0.003706:0.002942:0.001598:0.002596:0.004123:0.003695:0.002525:0.003695:0.001598:0.001873:0.002942:0.001598:0.003706:0.004123:0.001598:0.003706:0.002942:0.002942:0.003899:0.003074:0.001873:0.003706:0.002596:0.003695:0.004062:0.001598:0.002525:0.001873:0.002942:0.003604:0.001598:0.003899:0.002321:0.001598:0.004123:0.003695:0.004052:0.002525:0.003706:0.001944:0.001598:0.002596:0.004052:0.004062:0.003695:0.001598:0.004062:0.003695:0.002321:0.003695:0.003074:0.002596:0.002942:0.001598:0.002596:0.003899:0.001598:0.003074:0.004123:0.001873:0.001944:0.004062:0.002525:0.003695:0.004123:0.001598:0.003695:0.003461:0.004062:0.003899:0.002942:0.003695:0.004062:0.001598:0.002596:0.003899:0.001598:0.002576:0.004530:0.003604:0.004439:0.002861:0.004734:0.004052:0.003532:0.003706:0.003074:0.003899:0.002576:0.001598:0.004062:0.004052:0.002525:0.001873:0.004123:0.004062:0.001598:0.004062:0.002525:0.003695:0.004062:0.004123:0.003706:0.004123:0.003074:0.003522:0.001975:0.001598
ART: antiretroviral therapy; ARV: antiretroviral:@0.070706:0.909413:0.214562:0.909413:0.214562:0.900201:0.070706:0.900201:0.004428:0.004164:0.003604:0.001975:0.001598:0.003706:0.004123:0.002596:0.001873:0.002525:0.003695:0.002596:0.002525:0.003899:0.003532:0.001873:0.002525:0.003706:0.001944:0.001598:0.002596:0.004123:0.003695:0.002525:0.003706:0.004062:0.003522:0.001975:0.001598:0.004428:0.004164:0.004286:0.001975:0.001598:0.003706:0.004123:0.002596:0.001873:0.002525:0.003695:0.002596:0.002525:0.003899:0.003532:0.001873:0.002525:0.003706:0.001944
References: 1.:@0.070118:0.923614:0.120601:0.923614:0.120601:0.914223:0.070118:0.914223:0.004785:0.004265:0.002912:0.004265:0.002993:0.004265:0.004663:0.003288:0.004265:0.003298:0.002372:0.002403:0.004337:0.002372
 Meintjes G, Moorhouse MA, Carmona S, :@0.120601:0.923614:0.251314:0.923614:0.251314:0.914402:0.120601:0.914402:0.002403:0.006098:0.003695:0.001873:0.004123:0.002596:0.001914:0.003695:0.002942:0.002403:0.004439:0.001975:0.002403:0.006098:0.003899:0.003899:0.002525:0.004123:0.003899:0.004052:0.002942:0.003695:0.002403:0.006098:0.004428:0.001975:0.002403:0.003797:0.003706:0.002525:0.006312:0.003899:0.004123:0.003706:0.002403:0.003675:0.001975:0.001598
et al:@0.252119:0.923614:0.265943:0.923614:0.265943:0.914410:0.252119:0.914410:0.003441:0.002443:0.002250:0.003868:0.001822
. Adult antiretroviral therapy guidelines 2017. S Afr J HIV Med. 2017;18(1), a776. https://doi.org/10.4102/ sajhivmed.v18i1.776.   Updated recommendations on  rst-line and second-line antiretroviral regimens and :@0.265943:0.923614:0.956178:0.923614:0.956178:0.914402:0.265943:0.914402:0.001975:0.002403:0.004428:0.004062:0.004052:0.001944:0.002596:0.002403:0.003706:0.004123:0.002596:0.001873:0.002525:0.003695:0.002596:0.002525:0.003899:0.003532:0.001873:0.002525:0.003706:0.001944:0.002403:0.002596:0.004123:0.003695:0.002525:0.003706:0.004062:0.003522:0.002403:0.004062:0.004052:0.001873:0.004062:0.003695:0.001944:0.001873:0.004123:0.003695:0.002942:0.002403:0.003919:0.003919:0.003919:0.003919:0.001975:0.002403:0.003675:0.002403:0.004428:0.002321:0.002525:0.002403:0.002698:0.002403:0.004713:0.002026:0.004286:0.002403:0.006098:0.003695:0.004062:0.001975:0.002403:0.003919:0.003919:0.003919:0.003919:0.001975:0.003919:0.003919:0.002576:0.003919:0.002576:0.001975:0.002403:0.003706:0.003919:0.003919:0.003919:0.001975:0.002403:0.004123:0.002596:0.002596:0.004062:0.002942:0.001975:0.002861:0.002861:0.004062:0.003899:0.001873:0.001975:0.003899:0.002525:0.004062:0.002861:0.003919:0.003919:0.001975:0.003919:0.003919:0.003919:0.003919:0.002861:0.002403:0.002942:0.003706:0.001914:0.004123:0.001873:0.003532:0.006312:0.003695:0.004062:0.001975:0.003532:0.003919:0.003919:0.001873:0.003919:0.001975:0.003919:0.003919:0.003919:0.001975:0.001598:0.007513:0.002403:0.004652:0.004062:0.004062:0.003706:0.002596:0.003695:0.004062:0.002403:0.002525:0.003695:0.003074:0.003899:0.006312:0.006312:0.003695:0.004123:0.004062:0.003706:0.002596:0.001873:0.003899:0.004123:0.002942:0.002403:0.003899:0.004123:0.002403:0.002128:0.002128:0.002525:0.002942:0.002596:0.002840:0.001944:0.001873:0.004123:0.003695:0.002403:0.003706:0.004123:0.004062:0.002403:0.002942:0.003695:0.003074:0.003899:0.004123:0.004062:0.002840:0.001944:0.001873:0.004123:0.003695:0.002403:0.003706:0.004123:0.002596:0.001873:0.002525:0.003695:0.002596:0.002525:0.003899:0.003532:0.001873:0.002525:0.003706:0.001944:0.002403:0.002525:0.003695:0.004062:0.001873:0.006312:0.003695:0.004123:0.002942:0.002403:0.003706:0.004123:0.004062:0.001598
2.:@0.677364:0.923614:0.684073:0.923614:0.684073:0.914223:0.677364:0.914223:0.004337:0.002372
post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidance. Geneva: World Health  Organization; July 2018 (WHO/CDS/HIV/18.18). Licence: CC BY-NC-SA 3.0 IGO.   NUVACO approved package insert, October 2018.   Dlamini N. :@0.070118:0.931388:0.956076:0.931388:0.956076:0.922176:0.070118:0.922176:0.004062:0.003899:0.002942:0.002596:0.002840:0.003695:0.003461:0.004062:0.003899:0.002942:0.004052:0.002525:0.003695:0.003298:0.004062:0.002525:0.003899:0.004062:0.004123:0.003522:0.001944:0.003706:0.003461:0.001873:0.002942:0.003298:0.003706:0.004123:0.004062:0.003298:0.002525:0.003695:0.003074:0.003899:0.006312:0.006312:0.003695:0.004123:0.004062:0.003706:0.002596:0.001873:0.003899:0.004123:0.002942:0.003298:0.003899:0.004123:0.003298:0.003695:0.003706:0.002525:0.001944:0.003522:0.003298:0.001873:0.004123:0.002321:0.003706:0.004123:0.002596:0.003298:0.004062:0.001873:0.003706:0.004062:0.004123:0.003899:0.002942:0.001873:0.002942:0.003298:0.003899:0.002321:0.003298:0.004713:0.002026:0.004286:0.001975:0.003298:0.001873:0.004123:0.002596:0.003695:0.002525:0.001873:0.006312:0.003298:0.004062:0.004052:0.001873:0.004062:0.003706:0.004123:0.003074:0.003695:0.001975:0.003298:0.004439:0.003695:0.004123:0.003695:0.003532:0.003706:0.001975:0.003298:0.006658:0.003899:0.002525:0.001944:0.004062:0.003298:0.004713:0.003695:0.003706:0.001944:0.002596:0.004123:0.001598:0.001700:0.004540:0.002525:0.004062:0.003706:0.004123:0.001873:0.003186:0.003706:0.002596:0.001873:0.003899:0.004123:0.001975:0.003298:0.002698:0.004052:0.001944:0.003522:0.003298:0.003919:0.003919:0.003919:0.003919:0.003298:0.002576:0.006658:0.004713:0.004540:0.002861:0.003797:0.004530:0.003675:0.002861:0.004713:0.002026:0.004286:0.002861:0.003919:0.003919:0.001975:0.003919:0.003919:0.002576:0.001975:0.003298:0.003502:0.001873:0.003074:0.003695:0.004123:0.003074:0.003695:0.001975:0.003298:0.003797:0.003797:0.003298:0.004235:0.004011:0.002840:0.004734:0.003797:0.002840:0.003675:0.004428:0.003298:0.003919:0.001975:0.003919:0.003298:0.002026:0.004439:0.004540:0.001975:0.001598:0.008409:0.003298:0.004734:0.004652:0.004286:0.004428:0.003797:0.004540:0.003298:0.003706:0.004062:0.004062:0.002525:0.003899:0.003532:0.003695:0.004062:0.003298:0.004062:0.003706:0.003074:0.003604:0.003706:0.004062:0.003695:0.003298:0.001873:0.004123:0.002942:0.003695:0.002525:0.002596:0.001975:0.003298:0.004540:0.003074:0.002596:0.003899:0.004062:0.003695:0.002525:0.003298:0.003919:0.003919:0.003919:0.003919:0.001975:0.001598:0.008409:0.003298:0.004530:0.001944:0.003706:0.006312:0.001873:0.004123:0.001873:0.003298:0.004734:0.001975:0.001598
3.:@0.736643:0.931388:0.743352:0.931388:0.743352:0.921997:0.736643:0.921997:0.004337:0.002372
4.:@0.910103:0.931388:0.916811:0.931388:0.916811:0.921997:0.910103:0.921997:0.004337:0.002372
Health  minister  sees  new  ARV  drug  as  breakthrough  in   ght  against  HIV.  The  South  African  National  AIDS  Council.  2017 Oct  2  [cited  2018  Oct  19];  Available  from:  http://sanac.org.za/2017/10/02/health-minister-sees-new-arv-drug-as-breakthrough-in- ght-against-hiv/.:@0.070118:0.939162:0.954478:0.939162:0.954478:0.929950:0.070118:0.929950:0.004713:0.003695:0.003706:0.001944:0.002596:0.004123:0.001598:0.001639:0.006312:0.001873:0.004123:0.001873:0.002942:0.002596:0.003695:0.002525:0.001598:0.001639:0.002942:0.003695:0.003695:0.002942:0.001598:0.001639:0.004123:0.003695:0.005762:0.001598:0.001639:0.004428:0.004164:0.004286:0.001598:0.001639:0.004062:0.002525:0.004052:0.004062:0.001598:0.001639:0.003706:0.002942:0.001598:0.001639:0.004062:0.002525:0.003695:0.003706:0.003604:0.002596:0.004123:0.002525:0.003899:0.004052:0.004062:0.004123:0.001598:0.001639:0.001873:0.004123:0.001598:0.001639:0.002128:0.002128:0.004062:0.004123:0.002596:0.001598:0.001639:0.003706:0.004062:0.003706:0.001873:0.004123:0.002942:0.002596:0.001598:0.001639:0.004713:0.002026:0.004286:0.001975:0.001598:0.001639:0.003604:0.004123:0.003695:0.001598:0.001639:0.003675:0.003899:0.004052:0.002596:0.004123:0.001598:0.001639:0.004428:0.002321:0.002525:0.001873:0.003074:0.003706:0.004123:0.001598:0.001639:0.004734:0.003706:0.002596:0.001873:0.003899:0.004123:0.003706:0.001944:0.001598:0.001639:0.004428:0.002026:0.004530:0.003675:0.001598:0.001639:0.003797:0.003899:0.004052:0.004123:0.003074:0.001873:0.001944:0.001975:0.001598:0.001639:0.003919:0.003919:0.003919:0.003919:0.003247:0.004540:0.003074:0.002596:0.001598:0.001639:0.003919:0.001598:0.001639:0.002576:0.003074:0.001873:0.002596:0.003695:0.004062:0.001598:0.001639:0.003919:0.003919:0.003919:0.003919:0.001598:0.001639:0.004540:0.003074:0.002596:0.001598:0.001639:0.003919:0.003919:0.002576:0.001975:0.001598:0.001639:0.004428:0.003532:0.003706:0.001873:0.001944:0.003706:0.004062:0.001944:0.003695:0.001598:0.001639:0.002321:0.002525:0.003899:0.006312:0.001975:0.001598:0.001649:0.004123:0.002596:0.002596:0.004062:0.001975:0.002861:0.002861:0.002942:0.003706:0.004123:0.003706:0.003074:0.001975:0.003899:0.002525:0.004062:0.001975:0.003186:0.003706:0.002861:0.003919:0.003919:0.003919:0.003919:0.002861:0.003919:0.003919:0.002861:0.003919:0.003919:0.002861:0.004123:0.003695:0.003706:0.001944:0.002596:0.004123:0.002840:0.006312:0.001873:0.004123:0.001873:0.002942:0.002596:0.003695:0.002525:0.002840:0.002942:0.003695:0.003695:0.002942:0.002840:0.004123:0.003695:0.005762:0.002840:0.003706:0.002525:0.003532:0.002840:0.004062:0.002525:0.004052:0.004062:0.002840:0.003706:0.002942:0.002840:0.004062:0.002525:0.003695:0.003706:0.003604:0.002596:0.004123:0.002525:0.003899:0.004052:0.004062:0.004123:0.002840:0.001873:0.004123:0.002840:0.002118:0.002128:0.004062:0.004123:0.002596:0.002840:0.003706:0.004062:0.003706:0.001873:0.004123:0.002942:0.002596:0.002840:0.004123:0.001873:0.003532:0.002861:0.001975
  :@0.070118:0.946936:0.073314:0.946936:0.073314:0.937724:0.070118:0.937724:0.001598:0.001598
Nuvaco  lm coated tablet. Each  lm-coated tablet contains Lamivudine 300 mg, Tenofovir disoproxil fumarate 300 mg, Dolutegravir sodium equivalent to dolutegravir 50 mg. Reg. No. 52/20.2.8/0949. :@0.082478:0.958383:0.706685:0.958383:0.706685:0.949171:0.082478:0.949171:0.004734:0.004052:0.003532:0.003706:0.003074:0.003899:0.001598:0.002128:0.002128:0.001944:0.006312:0.001598:0.003074:0.003899:0.003706:0.002596:0.003695:0.004062:0.001598:0.002596:0.003706:0.004062:0.001944:0.003695:0.002596:0.001975:0.001598:0.003604:0.003706:0.003074:0.004123:0.001598:0.002128:0.002128:0.001944:0.006312:0.002840:0.003074:0.003899:0.003706:0.002596:0.003695:0.004062:0.001598:0.002596:0.003706:0.004062:0.001944:0.003695:0.002596:0.001598:0.003074:0.003899:0.004123:0.002596:0.003706:0.001873:0.004123:0.002942:0.001598:0.003502:0.003706:0.006312:0.001873:0.003532:0.004052:0.004062:0.001873:0.004123:0.003695:0.001598:0.003919:0.003919:0.003919:0.001598:0.006312:0.004062:0.001975:0.001598:0.003604:0.003695:0.004123:0.003899:0.002321:0.003899:0.003532:0.001873:0.002525:0.001598:0.004062:0.001873:0.002942:0.003899:0.004062:0.002525:0.003899:0.003461:0.001873:0.001944:0.001598:0.002321:0.004052:0.006312:0.003706:0.002525:0.003706:0.002596:0.003695:0.001598:0.003919:0.003919:0.003919:0.001598:0.006312:0.004062:0.001975:0.001598:0.004530:0.003899:0.001944:0.004052:0.002596:0.003695:0.004062:0.002525:0.003706:0.003532:0.001873:0.002525:0.001598:0.002942:0.003899:0.004052:0.001873:0.004052:0.006312:0.001598:0.003695:0.004062:0.004052:0.001873:0.003532:0.003706:0.001944:0.003695:0.004123:0.002596:0.001598:0.002596:0.003899:0.001598:0.004062:0.003899:0.001944:0.004052:0.002596:0.003695:0.004062:0.002525:0.003706:0.003532:0.001873:0.002525:0.001598:0.003919:0.003919:0.001598:0.006312:0.004062:0.001975:0.001598:0.004164:0.003695:0.004062:0.001975:0.001598:0.004734:0.003899:0.001975:0.001598:0.003919:0.003919:0.002861:0.003919:0.003919:0.001975:0.003919:0.001975:0.003919:0.002861:0.003919:0.003919:0.003919:0.003919:0.001975:0.001598
For full prescribing information, refer to the package insert approved by the Medicines Regulatory Authority. 2018111210108457.:@0.070120:0.966157:0.473081:0.966157:0.473081:0.956945:0.070120:0.956945:0.003512:0.003899:0.002525:0.001598:0.002321:0.004052:0.001944:0.001944:0.001598:0.004062:0.002525:0.003695:0.002942:0.003074:0.002525:0.001873:0.004062:0.001873:0.004123:0.004062:0.001598:0.001873:0.004123:0.002321:0.003899:0.002525:0.006312:0.003706:0.002596:0.001873:0.003899:0.004123:0.001975:0.001598:0.002525:0.003695:0.002321:0.003695:0.002525:0.001598:0.002596:0.003899:0.001598:0.002596:0.004123:0.003695:0.001598:0.004062:0.003706:0.003074:0.003604:0.003706:0.004062:0.003695:0.001598:0.001873:0.004123:0.002942:0.003695:0.002525:0.002596:0.001598:0.003706:0.004062:0.004062:0.002525:0.003899:0.003532:0.003695:0.004062:0.001598:0.004062:0.003522:0.001598:0.002596:0.004123:0.003695:0.001598:0.006098:0.003695:0.004062:0.001873:0.003074:0.001873:0.004123:0.003695:0.002942:0.001598:0.004164:0.003695:0.004062:0.004052:0.001944:0.003706:0.002596:0.003899:0.002525:0.003522:0.001598:0.004428:0.004052:0.002596:0.004123:0.003899:0.002525:0.001873:0.002596:0.003522:0.001975:0.001598:0.003919:0.003919:0.003919:0.003919:0.003919:0.003919:0.003919:0.003919:0.003919:0.003919:0.003919:0.003919:0.003919:0.003919:0.003919:0.003919:0.001975
Adcock Ingram Limited. Reg. No. 1949/034385/06. Private Bag X69, Bryanston, 2021, South Africa. Telephone + 27 11 635 0000. www.adcock.com:@0.070120:0.977600:0.527779:0.977600:0.527779:0.968388:0.070120:0.968388:0.004428:0.004062:0.003074:0.003899:0.003074:0.003604:0.001598:0.002026:0.004123:0.004062:0.002525:0.003706:0.006312:0.001598:0.003502:0.001873:0.006312:0.001873:0.002596:0.003695:0.004062:0.001975:0.001598:0.004164:0.003695:0.004062:0.001975:0.001598:0.004734:0.003899:0.001975:0.001598:0.003919:0.003919:0.003919:0.003919:0.002861:0.003919:0.003919:0.003919:0.003919:0.003919:0.003919:0.002861:0.003919:0.003919:0.001975:0.001598:0.004062:0.002525:0.001873:0.003532:0.003706:0.002596:0.003695:0.001598:0.004235:0.003706:0.004062:0.001598:0.003991:0.003919:0.003919:0.001975:0.001598:0.004235:0.002525:0.003522:0.003706:0.004123:0.002942:0.002596:0.003899:0.004123:0.001975:0.001598:0.003919:0.003919:0.003919:0.003919:0.001975:0.001598:0.003675:0.003899:0.004052:0.002596:0.004123:0.001598:0.004428:0.002321:0.002525:0.001873:0.003074:0.003706:0.001975:0.001598:0.003604:0.003695:0.001944:0.003695:0.004062:0.004123:0.003899:0.004123:0.003695:0.001598:0.006067:0.001598:0.003919:0.003919:0.001598:0.003919:0.003919:0.001598:0.003919:0.003919:0.003919:0.001598:0.003919:0.003919:0.003919:0.003919:0.001975:0.001598:0.005762:0.005762:0.005762:0.001975:0.003706:0.004062:0.003074:0.003899:0.003074:0.003604:0.001975:0.003074:0.003899:0.006312
A dolutegravir-based fixed dose combination :@0.158052:0.151934:0.869000:0.151934:0.869000:0.120268:0.158052:0.120268:0.022600:0.008042:0.020734:0.020157:0.009739:0.020326:0.012725:0.018528:0.020326:0.012793:0.017917:0.018256:0.009705:0.012997:0.011707:0.020869:0.018256:0.015168:0.018528:0.020734:0.008042:0.011843:0.009705:0.017137:0.018528:0.020734:0.008042:0.020734:0.020157:0.015168:0.018528:0.008042:0.015949:0.020157:0.029794:0.020869:0.009705:0.020428:0.018053:0.012929:0.009705:0.020157:0.019410:0.007024
regimen for :@0.219472:0.180438:0.409366:0.180438:0.409366:0.148772:0.219472:0.148772:0.012793:0.018528:0.020326:0.009705:0.029794:0.018528:0.020428:0.008042:0.011470:0.020157:0.013098:0.007024
first-line ART:@0.410384:0.180438:0.611713:0.180438:0.611713:0.148384:0.410384:0.148384:0.012182:0.010010:0.013574:0.015134:0.012827:0.011945:0.010010:0.010010:0.020123:0.018019:0.007262:0.021989:0.020360:0.017883
 in adults*:@0.612731:0.180438:0.770931:0.180438:0.770931:0.148772:0.612731:0.148772:0.008042:0.009705:0.020428:0.008042:0.018256:0.020734:0.020326:0.009739:0.012929:0.015168:0.014829
1-3:@0.771930:0.169108:0.800556:0.169108:0.800556:0.150646:0.771930:0.150646:0.011197:0.006825:0.010604
A new:@0.089968:0.661695:0.162914:0.661695:0.162914:0.634779:0.089968:0.634779:0.017191:0.005278:0.015864:0.013816:0.020796
era:@0.168221:0.661695:0.209064:0.661695:0.209064:0.634449:0.168221:0.634449:0.014451:0.010413:0.015979
for :@0.214342:0.661695:0.254176:0.661695:0.254176:0.634779:0.214342:0.634779:0.008884:0.015662:0.010009:0.005278
f irst-line ART rooted:@0.254176:0.661695:0.503443:0.661695:0.503443:0.634449:0.254176:0.634449:0.009490:0.000404:0.007644:0.010672:0.011999:0.010038:0.009288:0.007644:0.007644:0.016239:0.014451:0.005307:0.017826:0.016441:0.015201:0.005307:0.010672:0.016268:0.016124:0.009893:0.014566:0.016153
 in the need for a :@0.503443:0.661695:0.706936:0.661695:0.706936:0.634779:0.503443:0.634779:0.005278:0.007182:0.015864:0.005278:0.009605:0.015864:0.013816:0.005278:0.015864:0.013903:0.013903:0.015691:0.005278:0.008884:0.015662:0.010009:0.005278:0.015576:0.005278
healthier future:@0.706936:0.661695:0.902554:0.661695:0.902554:0.634449:0.706936:0.634449:0.016239:0.014451:0.015979:0.007644:0.010038:0.016239:0.007644:0.014451:0.010672:0.005307:0.009490:0.016153:0.010038:0.016153:0.010672:0.014451
1,4:@0.902541:0.652064:0.923998:0.652064:0.923998:0.636372:0.902541:0.636372:0.008727:0.004002:0.008727
Adcock Ingram ARVs: unwavering commitment to :@0.192262:0.686965:0.704962:0.686965:0.704962:0.664799:0.192262:0.664799:0.014799:0.013801:0.010452:0.013397:0.010665:0.012091:0.004917:0.006413:0.013587:0.013516:0.008243:0.012067:0.020143:0.004917:0.015107:0.013611:0.013492:0.009905:0.005606:0.004917:0.013516:0.013207:0.017649:0.011829:0.011758:0.012257:0.008456:0.006081:0.013587:0.013611:0.004917:0.010452:0.013397:0.020143:0.020143:0.006081:0.008337:0.020143:0.012257:0.013468:0.008337:0.004917:0.008195:0.013397:0.004917
quality:@0.704962:0.686965:0.777339:0.686965:0.777339:0.664527:0.704962:0.664527:0.013302:0.013041:0.013160:0.006295:0.006295:0.008480:0.011806
 and:@0.777339:0.686965:0.821711:0.686965:0.821711:0.664799:0.777339:0.664799:0.004917:0.012067:0.013587:0.013801
a ordability:@0.312052:0.708986:0.441438:0.708986:0.441438:0.686548:0.312052:0.686548:0.013373:0.007506:0.007506:0.013278:0.008789:0.013302:0.013160:0.013302:0.006295:0.006295:0.006295:0.008480:0.011806
 for people living with HIV:@0.441438:0.708986:0.706838:0.708986:0.706838:0.686820:0.441438:0.686820:0.004917:0.007316:0.013397:0.008456:0.004917:0.013896:0.012257:0.013397:0.013896:0.006105:0.012257:0.004917:0.006105:0.006081:0.012067:0.006081:0.013587:0.013611:0.004917:0.017792:0.006081:0.008337:0.013587:0.004917:0.015963:0.006271:0.014276
. Adult antiretroviral therapy guidelines 2017. S Afr J HIV Med. 2017;18(1), a776. https://doi.org/10.4102/ sajhivmed.v18i1.776.   Updated recommendations on  rst-line and second-line antiretroviral regimens and :@0.265947:0.923614:0.956185:0.923614:0.956185:0.914402:0.265947:0.914402:0.001975:0.002403:0.004428:0.004062:0.004052:0.001944:0.002596:0.002403:0.003706:0.004123:0.002596:0.001873:0.002525:0.003695:0.002596:0.002525:0.003899:0.003532:0.001873:0.002525:0.003706:0.001944:0.002403:0.002596:0.004123:0.003695:0.002525:0.003706:0.004062:0.003522:0.002403:0.004062:0.004052:0.001873:0.004062:0.003695:0.001944:0.001873:0.004123:0.003695:0.002942:0.002403:0.003919:0.003919:0.003919:0.003919:0.001975:0.002403:0.003675:0.002403:0.004428:0.002321:0.002525:0.002403:0.002698:0.002403:0.004713:0.002026:0.004286:0.002403:0.006098:0.003695:0.004062:0.001975:0.002403:0.003919:0.003919:0.003919:0.003919:0.001975:0.003919:0.003919:0.002576:0.003919:0.002576:0.001975:0.002403:0.003706:0.003919:0.003919:0.003919:0.001975:0.002403:0.004123:0.002596:0.002596:0.004062:0.002942:0.001975:0.002861:0.002861:0.004062:0.003899:0.001873:0.001975:0.003899:0.002525:0.004062:0.002861:0.003919:0.003919:0.001975:0.003919:0.003919:0.003919:0.003919:0.002861:0.002403:0.002942:0.003706:0.001914:0.004123:0.001873:0.003532:0.006312:0.003695:0.004062:0.001975:0.003532:0.003919:0.003919:0.001873:0.003919:0.001975:0.003919:0.003919:0.003919:0.001975:0.001598:0.007516:0.002403:0.004652:0.004062:0.004062:0.003706:0.002596:0.003695:0.004062:0.002403:0.002525:0.003695:0.003074:0.003899:0.006312:0.006312:0.003695:0.004123:0.004062:0.003706:0.002596:0.001873:0.003899:0.004123:0.002942:0.002403:0.003899:0.004123:0.002403:0.002128:0.002128:0.002525:0.002942:0.002596:0.002840:0.001944:0.001873:0.004123:0.003695:0.002403:0.003706:0.004123:0.004062:0.002403:0.002942:0.003695:0.003074:0.003899:0.004123:0.004062:0.002840:0.001944:0.001873:0.004123:0.003695:0.002403:0.003706:0.004123:0.002596:0.001873:0.002525:0.003695:0.002596:0.002525:0.003899:0.003532:0.001873:0.002525:0.003706:0.001944:0.002403:0.002525:0.003695:0.004062:0.001873:0.006312:0.003695:0.004123:0.002942:0.002403:0.003706:0.004123:0.004062:0.001598
2.:@0.677371:0.923614:0.684080:0.923614:0.684080:0.914223:0.677371:0.914223:0.004337:0.002372
post-exposure prophylaxis and recommendations on early infant diagnosis of HIV: interim guidance. Geneva: World Health  Organization; July 2018 (WHO/CDS/HIV/18.18). Licence: CC BY-NC-SA 3.0 IGO.   NUVACO approved package insert, October 2018. :@0.070118:0.931388:0.908483:0.931388:0.908483:0.922176:0.070118:0.922176:0.004062:0.003899:0.002942:0.002596:0.002840:0.003695:0.003461:0.004062:0.003899:0.002942:0.004052:0.002525:0.003695:0.003298:0.004062:0.002525:0.003899:0.004062:0.004123:0.003522:0.001944:0.003706:0.003461:0.001873:0.002942:0.003298:0.003706:0.004123:0.004062:0.003298:0.002525:0.003695:0.003074:0.003899:0.006312:0.006312:0.003695:0.004123:0.004062:0.003706:0.002596:0.001873:0.003899:0.004123:0.002942:0.003298:0.003899:0.004123:0.003298:0.003695:0.003706:0.002525:0.001944:0.003522:0.003298:0.001873:0.004123:0.002321:0.003706:0.004123:0.002596:0.003298:0.004062:0.001873:0.003706:0.004062:0.004123:0.003899:0.002942:0.001873:0.002942:0.003298:0.003899:0.002321:0.003298:0.004713:0.002026:0.004286:0.001975:0.003298:0.001873:0.004123:0.002596:0.003695:0.002525:0.001873:0.006312:0.003298:0.004062:0.004052:0.001873:0.004062:0.003706:0.004123:0.003074:0.003695:0.001975:0.003298:0.004439:0.003695:0.004123:0.003695:0.003532:0.003706:0.001975:0.003298:0.006658:0.003899:0.002525:0.001944:0.004062:0.003298:0.004713:0.003695:0.003706:0.001944:0.002596:0.004123:0.001598:0.001700:0.004540:0.002525:0.004062:0.003706:0.004123:0.001873:0.003186:0.003706:0.002596:0.001873:0.003899:0.004123:0.001975:0.003298:0.002698:0.004052:0.001944:0.003522:0.003298:0.003919:0.003919:0.003919:0.003919:0.003298:0.002576:0.006658:0.004713:0.004540:0.002861:0.003797:0.004530:0.003675:0.002861:0.004713:0.002026:0.004286:0.002861:0.003919:0.003919:0.001975:0.003919:0.003919:0.002576:0.001975:0.003298:0.003502:0.001873:0.003074:0.003695:0.004123:0.003074:0.003695:0.001975:0.003298:0.003797:0.003797:0.003298:0.004235:0.004011:0.002840:0.004734:0.003797:0.002840:0.003675:0.004428:0.003298:0.003919:0.001975:0.003919:0.003298:0.002026:0.004439:0.004540:0.001975:0.001598:0.008489:0.003298:0.004734:0.004652:0.004286:0.004428:0.003797:0.004540:0.003298:0.003706:0.004062:0.004062:0.002525:0.003899:0.003532:0.003695:0.004062:0.003298:0.004062:0.003706:0.003074:0.003604:0.003706:0.004062:0.003695:0.003298:0.001873:0.004123:0.002942:0.003695:0.002525:0.002596:0.001975:0.003298:0.004540:0.003074:0.002596:0.003899:0.004062:0.003695:0.002525:0.003298:0.003919:0.003919:0.003919:0.003919:0.001975:0.001598
3.:@0.736723:0.931388:0.743432:0.931388:0.743432:0.921997:0.736723:0.921997:0.004337:0.002372
 for people living with HIV:@0.441435:0.708992:0.706835:0.708992:0.706835:0.686825:0.441435:0.686825:0.004917:0.007316:0.013397:0.008456:0.004917:0.013896:0.012257:0.013397:0.013896:0.006105:0.012257:0.004917:0.006105:0.006081:0.012067:0.006081:0.013587:0.013611:0.004917:0.017792:0.006081:0.008337:0.013587:0.004917:0.015963:0.006271:0.014276
A CLEAN AND CLEAR FIRST CHOICE:@0.109530:0.100061:0.387244:0.100061:0.387244:0.083598:0.109530:0.083598:0.011588:0.003654:0.010701:0.009239:0.009639:0.011762:0.012180:0.003654:0.011762:0.012354:0.012284:0.003654:0.010701:0.009239:0.009639:0.011762:0.010492:0.003654:0.009518:0.005307:0.010666:0.009744:0.009709:0.003654:0.010701:0.012336:0.012823:0.005307:0.010701:0.009291
1,2:@0.387410:0.094251:0.401307:0.094251:0.401307:0.084653:0.387410:0.084653:0.005630:0.002637:0.005630
Dolutegravir 50 mg + Lamivudine 300 mg  :@0.422035:0.067512:0.913117:0.067512:0.913117:0.042253:0.422035:0.042253:0.018488:0.015267:0.006957:0.015402:0.009339:0.013967:0.015402:0.009393:0.013480:0.013751:0.006930:0.009637:0.005603:0.014509:0.014509:0.005603:0.022954:0.015510:0.005603:0.016133:0.005603:0.013345:0.013751:0.022954:0.006930:0.013751:0.015402:0.015727:0.006930:0.015483:0.013967:0.005603:0.014509:0.014509:0.014509:0.005603:0.022954:0.015510:0.000000:0.005603
+ Tenofovir disoproxil fumarate 300 mg:@0.422035:0.091945:0.881121:0.091945:0.881121:0.066685:0.422035:0.066685:0.016133:0.004520:0.012127:0.013967:0.015483:0.015267:0.008337:0.015050:0.013751:0.006930:0.009637:0.005603:0.015727:0.006930:0.011288:0.015267:0.015835:0.009393:0.014752:0.013372:0.006930:0.006957:0.005603:0.008635:0.015402:0.022954:0.013751:0.009393:0.013588:0.009339:0.013967:0.005603:0.014509:0.014509:0.014509:0.005603:0.022954:0.015510